Variables | Population (n = 55) |
Demographics |
|
Age (mean ± SD, years) | 30.3 ± 13.1 |
Gender (women:men) | 53:2 |
Caucasian vs no causasian | 34.5:65.5 |
Smokers vs no smokers | 9:46 |
Disease characteristics |
|
Disease duration* (mean ± SD, years) | 4.2 ± 9.6 |
Self-reported symptoms |
|
Alopecia, n(%) | 41 (74.5) |
Raynaud phenomenon, n(%) | 11 (20) |
Skin lesions, n(%) | 34 (61.8) |
Dyspnea**, n(%) | 25 (45.4) |
Pleuritic chest pain**, n(%) | 19 (34.5) |
Dry cough**, n(%) | 16 (29.1) |
Productive cough**, n(%) | 2 (3.6) |
Medications at study entry |
|
Prednisone (yes/no) | 45 |
Methotrexate (yes/no) | 10 |
Hydroxychloroquine (yes/no) | 50 |
Mycophenolate mofetil (yes/no) | 03 |
Azathioprine (yes/no) | 05 |